Clinical Trial Update: Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, pharmacokinetics, oral bioavailability, food effect, and drug-drug interactions of APX001 in fungal infections; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infections

Drugs mentioned

• APX001 (fosmanogepix)

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Fungal Infection | Phase 1 | Status: COMPLETED